Vasil'kov V G, Safronov A I, Kelina N Iu, Begunov V A
Anesteziol Reanimatol. 1995 Sep-Oct(5):23-7.
The course of diffuse peritonitis has been followed up in 219 patients, 20 of these with the reactive, 165 with toxic, and 34 with the terminal stages of the condition. Multiple-modality intensive care included, besides routine therapy, local abdominal hypothermia, UV irradiation of autoblood (UVIAB), and, if indicated, hyperbaric oxygenation (HBO) and hemoperfusion. In addition to clinical tests, immunobiochemical monitoring of medium-molecular peptide fractions MM1 and MM2 and index of their distribution, as well as of circulating immune complexes CIC1 and CIC2 and the levels of immunoglobulins IgA, IgM, and IgG were the criteria for assessing the severity of intoxication and efficacy of intensive care and for predicting the course and outcome of the disease. The results indicate that HBO in combination with hemoperfusion, local abdominal hypothermia, and UVIAB have a positive impact on the clinical picture of the disease and on the time course of markers of endogenous intoxication and humoral immunity in patients with the terminal and toxic phases of diffuse peritonitis.
对219例弥漫性腹膜炎患者的病程进行了随访,其中20例处于反应期,165例处于中毒期,34例处于疾病终末期。多模式重症监护除常规治疗外,还包括局部腹部低温治疗、自血紫外线照射(UVIAB),并在必要时进行高压氧治疗(HBO)和血液灌流。除临床检查外,对中分子肽组分MM1和MM2及其分布指数、循环免疫复合物CIC1和CIC2以及免疫球蛋白IgA、IgM和IgG水平进行免疫生化监测,作为评估中毒严重程度、重症监护疗效以及预测疾病病程和转归的标准。结果表明,HBO联合血液灌流、局部腹部低温治疗和UVIAB对弥漫性腹膜炎终末期和中毒期患者的疾病临床表现以及内源性中毒和体液免疫标志物的时间进程有积极影响。